期刊名称：JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.
Published monthly, the Journal features original articles on the laboratory aspects and clinical use of antimicrobials including antibacterial, antiviral, antifungal, and antiprotozoal agents.
In addition to the wealth of primary papers, the journal carries review articles offering in-depth discussion on matters of topical concern. Lively leading articles offer incisive coverage of recent advances and controversies.
Other sections include:
- For debate
International comment on contentious issues and ideas
- Antimicrobial practice
Articles on practical prescribing and formulary issues
- Correspondence
A section for scientists to present early observations of their work and to comment on published articles
- Book reviews
Helpful reviews of relevant, newly published titles
A carefully organised format directs you to areas of interest.
Monthly issues can include up to ten informative sections:
- Leading articles
- Reviews
- The Garrod Lecture
- For debate
- Original articles
- Brief reports
- Antimicrobial practice
- Meeting reports
- Correspondence
- Book reviews
The Journal publishes between two and eight supplements each year. These include Working Party reports of the British Society for Antimicrobial Chemotherapy, and original publications on pre-clinical and clinical aspects of drugs in development or the role of established drugs in specific therapeutic areas.
|
 |
Instructions to Authors
Instructions to Authors
SCOPE OF THE JOURNAL
EDITORIAL OFFICE CONTACT INFORMATION
ETHICS
AUTHORSHIP
SUBMISSION OF PAPERS
STYLE
ONLINE SUBMISSION DETAILS
PROCESSING OF PAPERS
The Journal will consider for publication articles on all aspects of antimicrobial chemotherapy. The following types of articles are published: Leading articles, Reviews, Original articles, Brief reports, Antimicrobial Practice, Correspondence and Book reviews.
JAC Editorial Office
11 The Wharf
16 Bridge Street
Birmingham
B1 2JS
UK
Tel: +44 121 633 0415
Fax: +44 121 643 9497
E-mail: jac@bsac.org.uk
In reports of investigations in humans or animals authors should indicate their adherence to ethical standards and may note the approval of an ethics committee when this is relevant. Patients must not be referred to by their own initials or hospital numbers. Work offered for publication in the Journal must conform to the standards for experimentation and care set down in the UK Animals (Scientific Procedures) Act of 1986 and the Code of Practice for the Housing and Care of Animals used in Scientific Procedures 1989. Authors who are in doubt about complying with these provisions should contact the Editorial Office.
Sources of financial support for work reported, ongoing support for any of the authors and any conflicting interests should be stated in the Acknowledgements.
The authorship of the paper should be confined to those who have made a significant contribution to the design and execution of the work described.
Material offered for publication must be original, unpublished and not under simultaneous consideration by another journal. Any previous publication of the material (including conference proceedings, letters to journals and brief communications) must be declared. For these purposes the posting of essentially raw data on a website without significant analysis, is not considered to represent prior publication.
Please note that the Journal requires the original signatures of ALL authors. The Journal reserves the right to remove the name of any author from the author list if their signed consent cannot be obtained for any reason.
The Journal also requires written confirmation of permission for the inclusion of any material cited as a 'personal communication' from the person named. Written permission from the copyright holder must be provided if the authors wish to make use of previously published material.
Responsibilities of the corresponding author
As the representative of the authors, the corresponding author must ensure that all authors are given access to submitted and revised versions of papers. The corresponding author is responsible for the collation of the authors signatures on submission letters and also the collation and communication of proof corrections to the Journal. The corresponding author should be the signatory of the copyright licence form. As the authors¡¯ nominated representative, the corresponding author will be held primarily accountable for any failure to comply with the Instructions to authors or generally accepted standards of good practice. This does not absolve other authors of responsibility, however. The corresponding author will act as the primary contact for correspondence regarding the paper, and as such authors should take care not to appoint a corresponding author likely to be absent for extended periods (such as a sabbatical) during the consideration of the paper as this is likely to cause unacceptable delays
Please note that papers submitted via Manuscript Central must be submitted through the account of the corresponding author listed on the paper, not through the account of one of the other authors or the account of a third party who is not on the author list.
Where to submit
All material to be considered for publication should be submitted in electronic form via the Journal¡¯s online submission system at:
http://jac.manuscriptcentral.com
Given that you can produce a file of your paper through a word processing package of some description, you only need the three following items to access and use the system: access to the website via a web browser, Adobe Acrobat Reader (which can be downloaded free of charge from http://www.adobe.com/) and an e-mail account. For more guidance see the section Online submission details.
In addition to submitting your paper online you should simultaneously provide a written statement, signed by all the authors indicating that you have complied with the stipulations in the Instructions to authors. A copy with the original signatures must be sent to the Editorial Office as soon as possible after online submission. A blank form is available on the 'Instructions and Forms' section of the JAC Manuscript Central website. If at any stage during consideration the authorship of the article changes, the authors must supply a signed statement from ALL the authors (including any whose names are being removed) explicitly indicating the nature of the changes and their agreement.Be aware that the Journal will NOT publish any article until it has received both:
- The appropriate author submission letter bearing the necessary original signatures;
- A copyright licence form bearing an original signature (a fax is NOT acceptable).
Papers in press
In-press and submitted papers that are important for the review of your paper should also be uploaded when you submit your paper online.
Supplementary data
Please note that it is also possible to include files containing supplementary data. The supplementary data (for example large tables of MICs, or a questionnaire) can be lodged with the version of the paper published online as an extra resource for readers. Please contact the Editorial Office if you would like further details.
Assignment of copyright
Papers are considered on the understanding that after acceptance and before publication the authors will grant an exclusive licence to publish to the British Society for Antimicrobial Chemotherapy.
Article format
All documents should be double spaced, with wide margins. A clear, legible single font (which is readily available) and point size should be employed throughout. All submitted articles should be page numbered and line numbered.
Original articles and Brief reports should have a structured synopsis. The headings for the structured synopsis are as follows: Objectives, Patients and methods (or Methods), Results, and Conclusions. Authors should also provide 3-5 keywords. Very general terms such as ¡®bacteria¡¯ and ¡®human¡¯ and terms already present in the title should be avoided, as should non-standard abbreviations.
Original articles. There is no length limit for this format; however, papers must be written as concisely as possible. Original articles are divided into the following sections: Synopsis (250 words maximum), Introduction, Materials (or Patients) and methods, Results, Discussion, Acknowledgements and References. Repetition of content between sections must be avoided. A combined Results and Discussion section is acceptable.
Brief reports. These should have the same format as Original articles but have a synopsis of not more than 250 words, not more than 1500 words of text and no more than two figures or tables and 10 references.
Antimicrobial practice. Short articles on topics related to the use of antimicrobials, format as for Brief reports.
Correspondence. Letters on topics of concern or interest in the field of antimicrobial chemotherapy, particularly arising from papers or letters already published in the Journal. These should be addressed to the Editor-in-Chief and must not exceed 800 words, one figure or table and six references.
Review articles. There is no length limit for this format. These generally aim to give an overview of a field suitable for a wide audience. Most reviews are invited. We are pleased to consider unsolicited reviews, but authors are encouraged to consult the Editor-in-Chief in advance of writing to avoid duplicating commissioned material.
Leading articles. These are usually in the region of 800-1000 words and may contain the expression of opinion as well as fact. They should address a topical subject, perhaps taking a particular viewpoint and throwing new light on a current debate. Those wishing to contribute a Leading article are encouraged to contact the Editor-in-Chief to discuss their ideas before writing to prevent clashes with any articles already in the pipeline.
General
In addition to reading the information provided here, authors should consult a recent issue of the Journal for the layout and conventions used.
The past tense should be used throughout for description of the results of the paper, the present tense should be used when referring to previously established and generally accepted results.
Where possible SI units should be used.
Spelling
British spelling should be used. Spelling should follow that of the Oxford Dictionary for Scientific Writers and Editors and where this gives no guidance the Concise Oxford Dictionary. Spelling of drug names should conform with that given in the latest edition of the British National Formulary (published by the British Medical Association and the Royal Pharmaceutical Society of Great Britain and available online at http://www.bnf.org/webnf/lform1/bnf/index.html).
Abbreviations
Non-standard abbreviations should be defined at the first occurrence and introduced only where multiple use is made. The following abbreviations may be used without definition:
Organizations
ATCC American Type Culture Collection
CDC Centers for Disease Control (and Prevention) (USA)
CDSC Communicable Disease Surveillance Centre (UK)
MRC Medical Research Council (UK)
NCCLS National Committee for Clinical Laboratory Standards
NIH National Institutes of Health (USA)
WHO World Health Organization
General
AIDS acquired immunodeficiency syndrome
AMP, ADP, ATP etc. adenosine 5 ¢-phosphate, adenosine 5¢-diphosphate, adenosine 5¢-triphosphate
bp base pair(s)
BSA bovine serum albumin
cfu colony-forming unit(s)
CNS central nervous system
cpm counts per min
CSF cerebrospinal fluid
Da dalton(s)
DNA, cDNA deoxyribonucleic acid, complementary DNA
dpm disintegrations per min
ELISA enzyme-linked immunosorbent assayg acceleration due to gravity
h hour(s)
HEPES 4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid
HPLC high-performance (or high-pressure) liquid chromatography
ID50 50% infective dose
IU international unit(s)
kg kilogram(s)
L litre(s)
LD50 50% lethal dose
m metre(s)
MBC minimum bactericidal concentration
MIC minimum inhibitory concentration
min minute(s)
MLD minimum lethal dose
mol. wt molecular weight
MOPS 4-morpholinepropanesulphonic acid
nt nucleotide(s)
P probability
PAGE polyacrylamide gel electrophoresis
PBS phosphate-buffered saline
PCR polymerase chain reaction
PFGE pulsed-field gel electrophoresis
pfu plaque-forming unit(s)
ppm parts per million
RNA ribonucleic acid
rpm revolutions per min
RT©¤PCR reverse transcriptase PCR
s second(s)
SDS sodium dodecyl sulphate
sp./spp. species (singular)/species (plural)
Tris 2-amino-2-hydroxymethylpropane-1,3-diol
U unit(s)
Dosage and route of administration
Dosage frequencies should be given in full in English at each occurrence. Abbreviations are not permitted. Routes of administration other than intramuscular (im) and intravenous (iv), which may be abbreviated after definition, should be given in full in English.
Pharmacokinetics
AUC area under the concentration-time curve
AUC0¨C24 and AUC0¨C¡Þ AUC from 0¨C24 h and AUC from 0 h to infinity
CL clearance
CLCR creatinine clearance
CLNR non-renal clearance
CLR renal clearance
Cmax maximum concentration of drug in serum
kel elimination rate constant
kss residence rate constant at steady state
t½ half-life
Tmax time to maximum concentration of drug in serum
V volume of distribution
Vmax maximum rate of metabolism
Vss volume of distribution at steady state
Pharmacodynamics
For acceptable abbreviations and their definitions please refer to the article by Mouton et al. [Mouton, J. W., Dudley, M. N., Cars, O., Derendorf, H. & Drusano, G. L. (2002) Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs. International Journal of Antimicrobial Agents 19, 355-8.]
Bacterial nomenclature
When genus and species are given together use a capital letter for the genus and a lowercase letter for the species and italicize both e.g. Staphylococcus aureus. After the initial use in the text of the full name of an organism the generic name should then be abbreviated to the initial letter, e.g. E. coli.
When the genus is used as a noun or adjective use lowercase roman unless the genus is specifically referred to e.g. ¡®staphylococci and streptococci¡¯ but ¡®organisms of the genera Staphylococcus and Streptococcus¡¯.
The name of an order has an initial capital but is not italicized, e.g. Enterobacteriaceae. For genera in the plural, use lowercase roman, e.g. salmonellae.
When the species is used alone use lowercase e.g. viridans streptococci. For trivial names, use lowercase roman e.g. meningococcus.
Genetic and amino acid nomenclature
Bacterial genetics. Genotype designations are indicated with italic lowercase three-letter locus codes (e.g. par, his, ara). If several loci are involved in a related function the individual loci are designated by the addition of an uppercase italic letter to the locus code (parC, ompF).
Phenotype designations (for example the protein product of a bacterial gene) are given in roman type with an initial capital letter (OmpF, LacZ).
Erythromycin gene nomenclature should follow that described in: Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J. & Seppala, H. (1999). Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrobial Agents and Chemotherapy 43, 2823¨C30.
Yeast genetics. Wild-type alleles are all uppercase and italicized (LEU2), mutant alleles are all lowercase and italicized (leu2), and gene products are capitalized on the first letter and are not italicized (Leu2).
General. Authors should ensure that they confine discussion of changes in amino acid sequence to the context of the protein (e.g. OmpF) and nucleotide changes to the context of the gene (e.g. ompF). Please also be aware of the difference between a mutant (a strain with one or more mutations) and a mutation (a change in the sequence of the genetic material).
Amino acids. The full residue names or three-letter abbreviations are preferred in the text (e.g. a methionine residue at position 184 should be symbolized Met-184 or Met184). The single letter codes may be used in figures. Amino acid changes should be designated Met-184®Val, Met184®Val or M184V.
When comparing nucleotide or amino acid sequences authors should exercise care in the use of the term homology. Homology should only be used when a common evolutionary origin is being implied; it is incorrect to give a percentage homology between two sequences. The wing of a bird and the human arm are homologous structures (they are believed to have a common evolutionary origin), homology cannot be quantified. For sequence comparison authors should use the terms identity and similarity. Sometimes ¡®equivalent¡¯ or ¡®counterpart¡¯ is more appropriate than ¡®homologue¡¯.
FICI data
Fractional inhibitory concentration index (FICI) experiments are performed in order to study drug interactions and they must be interpreted in the following way:
FICI¡Ü0.5 = synergy
FICI>4.0 = antagonism
FICI>0.5-4 = no interaction
Chemistry
General nomenclature. The IUPAC recommendations on chemical nomenclature should be followed (IUPAC Compendium of Chemical Terminology (1987, ISBN 0 632 01767 8, Blackwell Scientific Publications, Oxford). All chemical names are run together except those of acids, acetals, esters, ethers, glycosides, ketones and salts, which are printed as separate words; hyphens are used to separate numbers, Greek letters and some configurational prefixes, e.g. p-nitrophenol. Italics are used for certain prefixes, e.g. cis-, trans- and N. Small capitals are used for dextro- and laevo- prefixes, e.g. L-glutamine.
Drugs. Spelling of drug names should conform with that given in the latest edition of the British National Formulary. Chemical or generic names of drugs should be used; trade names may be referred to once only upon first use of the generic or chemical name. Proprietary symbols (©, ® and ™) should not be used. The content of proprietary formulations should be given if relevant. Generic names should not be abbreviated in the text; abbreviations may be used in Tables if there is limited space. If compounds are referred to by code name or company number either the structure or a reference to a paper illustrating the structure must be given, any previous code names or designations should be given on first use.
Supplier locations are required for all smaller/local suppliers.
References
Authors are responsible for the accuracy of all references, which must be checked against the original material. Reference citations should be restricted to those that are essential for introducing the purpose and context of the paper, describing methods that are not given in detail, and for discussing the results and any relevant issues raised by them. Authors are responsible for ensuring that references are quoted accurately and not taken out of context. References must not be cited in the synopsis.
Each reference is numbered in order of appearance in the manuscript. For citations in the text superscript numbers are to be used and placed after any punctuation. When referring to several references, separate individual numerals by a comma or a hyphen for a range greater than two references. For instance: This was first discovered by Jones,1 and later confirmed by several other groups of investigators.2,3,5¨C7
Papers accepted for publication, but not yet published, may be cited in the usual way in the text, and listed as ¡®in press¡¯, with the name of the journal and the likely year of publication. Submitted work should be quoted in the text as ¡®unpublished results¡¯. Personal communications or unpublished work, referred to in the text, must include the names of all the workers responsible with their initials; for the former citation, documentary evidence from the person quoted showing agreement with the quotation must be provided.
All references should be listed numerically at the end of the text. Each reference is preceded by a number (not superscript) followed by a full stop, please refer to the list below for specific examples (failure to conform to Journal style will result in the manuscript being returned to authors).
References should be in the form: author¡¯s surnames with initials of first names (all authors¡¯ names should be given unless they exceed three, when three authors et al. should be used), year of publication in parentheses, full title of paper, journal name in full (italics) volume (bold), first and last page numbers.
Examples:
Journal reference (¡Ü three authors)
Naas, T., Bellais, S. & Nordmann, P. (2003). Molecular and biochemical characterization of a carbapenem-hydrolysing ¦Â-lactamase from Flavobacterium johnsoniae. Journal of Antimicrobial Chemotherapy 51, 267¨C73.
Journal reference (> three authors)
Williams, I., Gabriel, G., Cohen, H. et al. (1989). Zidovudine ¨C the first year of experience. Journal of Infection 18, Suppl. 1, 23¨C31.
Whole book
Odds, F. C. (1988). Candida and Candidosis, 2nd edn. Bailli¨¨re Tindall, London, UK.
Book chapter
Peutherer, J. F. (1992). Retroviruses. In Medical Microbiology, 14th edn (Greenwood, D., Slack, R. C. B. & Peutherer, J. F., Eds), pp. 627¨C38. Churchill Livingstone, Edinburgh, UK.
NCCLS methods
National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically¡ªSecond Edition: Approved Standard M7-A2. NCCLS, Villanova, PA, USA.
Meeting abstract
Knapp, C. C., Ludwig, M. D., Barthel, J. S. et al. (1990). Variables affecting the susceptibility of Helicobacter pylori to metronidazole. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, 1990. Abstract 877, p. 232. American Society for Microbiology, Washington, DC, USA.
Online material
References to online material should be given in the reference list. It is important that the date you last accessed the site be included and that you check the site at the proof stage to ensure that the material is still available. Please note that URLs for the suppliers of materials must not be given in either the text or the references. The Journal does not accept any responsibility for the content of web pages cited.
Smith, B. (2000). Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? [Online.] http://www.jac.oupjournals.org (12 June 2001, date last accessed).
Tables
These should be employed sparingly and should be generally comprehensible without reference to the text. Each table should be supplied on a separate sheet and numbered consecutively using Arabic numerals in the order they are referred to in the text. Each must have a brief descriptive heading. Column headings must clearly explain the content of the column and indicate any units used. Footnotes should be kept to a minimum.
When preparing tables for submission, use either your word processor's Table function or ensure that items in adjacent columns are separated by a single tab character. Do not use multiple spaces to achieve alignments.
Figures
These must be employed sparingly to demonstrate important specific points. Figures should be numbered using Arabic numerals in the order in which they are referred to in the text. In figure LEGENDS, symbols should be described in words (e.g. filled circles, open squares etc.).
Wherever possible, figures should be two-dimensional. Authors should NOT supply 'three-dimensional' figures unless this is actually necessary to represent the data.
Halftone images (e.g. photomicrographs) must be of high quality; the quality of reproduction in the journal is limited by the quality of the submitted material. Images should be sharply focused and have good contrast. Colour illustrations can be reproduced if there is sufficient scientific merit in doing so. Authors will be expected to bear the cost of colour origination by the Journal¡¯s printers (the minimum cost will be £695).
General
You will need a username and password to access the online submission site (http://jac.manuscriptcentral.com); if you have previously corresponded with the JAC, either as an author or referee, then it is likely that you will already have an account. To check if you are already registered, click on the 'Check for existing account' button on the login screen, and follow the on-screen instructions. If you do not have an account, you can create one by clicking on 'Create a new account'.
Please note that papers submitted via Manuscript Central must be submitted through the account of the corresponding author listed on the paper, not through the account of one of the other authors or the account of a third party who is not on the author list.
All correspondence relating to a submission (e.g. acknowledgement of receipt, communication of decisions etc.) will be sent via e-mail to the corresponding author.
Preparing your manuscript prior to online submission
Prepare your manuscript using a word processing program. Please ensure that you only use readily available fonts. The journal prefers all manuscripts submitted online to be Microsoft Word files (.doc). During the online submission process these will be converted automatically to .pdf files (for peer review). If you are unable to submit a Word file, you can submit manuscripts in other formats, for example as .pdf, .rtf or .ps files. These last two file types will also be converted into .pdf format on submission. pdf files are readable with Adobe Acrobat Reader, which is available for download (free of charge) from the Instructions and Forms page of Manuscript Central (as well as from http://www.adobe.com/).
Microsoft Excel spreadsheets may be uploaded and will be converted into .pdf format. It is also possible to upload LaTeX files but these will not be automatically converted into .pdf format (and are therefore discouraged). The journal staff, Editors and reviewers will only be able to view these unconverted files if they have the appropriate software on their computer, which cannot be guaranteed.
Please note that the uploading of PowerPoint files is barred owing to their large size. Powerpoint presentations can be saved as .tif, .jpg or .gif files and then embedded in a document and uploaded (see below).
We prefer that authors upload a single file containing the complete manuscript (i.e. title page, abstract, text, figures and tables), as this makes the reviewing process easier for Editors and referees. This applies to the original version of the manuscript and any revised versions.
Image files should be saved in one of the following formats - Joint Photographic Experts Group (.jpg); Graphics Interchange Format (.gif); Tagged Image File format (.tif); or Encapsulated PostScript (.eps). When inserting figures into your text documents, please make sure any embedded text is large enough to read. Many figures contain miniscule characters such as numbers on a chart or graph. If these characters are not easily readable in your text document, they will most likely be illegible in the .pdf created by the system. Certain image formats such as .jpg and .gif do not have high resolutions, so you may elect to save your figures and insert them as .tif instead.
Please note, that authors submitting REVISED manuscripts will be required to provide high-resolution images for publication purposes.
Please use short, simple filenames when saving all your documents, and avoid special characters (such as brackets), punctuation marks and symbols (such as &). Also avoid spaces in your filenames. If you are a Macintosh user, in addition to using simple, short filenames when saving your documents, you must type the extension at the end of the file name you choose (.doc, .rtf, .jpg, .gif, .tif, .xls, .pdf, .eps, .mov or .qt).
During the online manuscript submission process you can also upload any other files you might want reviewed, including in-press and submitted papers.
The online submission process
Before you start
Before starting the online submission process please make sure you have the following available:
- A file with your complete manuscript (i.e. title page, abstract, text, figures and tables) in one of the formats detailed above;
- If the images are not embedded in your text file (preferred), the image files;
- The files for any other supplementary material to be submitted with your manuscript;
- The text of your abstract (can be cut and pasted into the system from your word processor file);
- Where appropriate, the names and e-mail addresses of all contributing authors.
Submitting your manuscript
1. Go to the website at: http://jac.manuscriptcentral.com
2. If you have a username and password for the site, logon now. If you do not, check to see if you are already registered by clicking on the 'Check for Existing Account' button and following the on-screen instructions. If you are not already registered, you can register yourself by clicking on the 'Create a New Account' button on the login screen and following the on-screen instructions.
If you have problems with your account do not create another account. Please contact the JAC Editorial Office.
3. Once you have logged on, proceed to the Author centre by clicking on the 'Author Centre' button.
4. In the Author Centre click on 'Submit First Draft of a New Manuscript' to begin the submission process.
5. Now follow the on-screen instructions. There are 12 steps for you to follow to submit your manuscript. You move from one step to the next by clicking on the 'Save and Continue' button on each screen. At any stage you can stop the submission process by clicking on the 'Return to Menu' button - everything you have typed in to the system up to, but not including, the current screen will be saved. To return to the submission process you will need to click on the manuscript title in the 'Partially Submitted Manuscripts' section in your Author Centre.
6. The penultimate step in the submission process is to upload your manuscript files to the system. There are four steps you have to follow for each file you upload:
- Choose the file to upload - use the browse button to find and select the file you want to upload;
- Select the designation of the file - from the drop-down list, choose the designation of the file you are uploading; for example, is the file the main document, an image file, etc.
- Designate whether this file is for review or not - Choose 'no' only if you do not want the file to go to peer review. For example, you may want to upload a high-resolution image file that will not go to review but may be used if the manuscript is published. Please be advised that if you select 'no' the editorial staff will still be able to view that document and make it available to a reviewer if necessary.
- Upload - Click on the upload button to submit your file. If you are uploading your manuscript file, and it is in one of the formats specified above, it will automatically get converted into a .pdf file for peer review.
If your file is successfully uploaded you will see an upload confirmation window where you can type in a brief description for the file (e.g. ¡®Article Text¡¯, ¡®Figure 1¡¯ etc.). Once you have typed in your description click on 'Save Description' to finish the uploading of your file.
Repeat these four steps for each file you want to upload. Once you have finished uploading your manuscript file(s) click on 'Save and Continue'.
7. Before submitting your manuscript you must first check the uploaded files(s) to make sure your manuscript has successfully passed to the system. To do this click on the 'View Your Proof as will be seen by reviewers' button. This will launch a new web browser window with the names of the file(s) you have just uploaded. Click on the file name to view the file. When you have viewed the files click on 'Close Window' to return to the submission screen.
If the files have not been uploaded to your satisfaction, click on the 'Previous' button to move back to the file upload screen where you can delete the files you do not want, and repeat the upload process.
8. Once you are happy with the uploaded file(s) you can submit your manuscript for review to the Journal by clicking on the 'Submit Your Manuscript' button. It is not until this button is pushed that the manuscript and all of the associated information (i.e. contributing authors, institutions, etc.) is linked together and the manuscript is given a manuscript number. Once the manuscript is submitted it is not possible to undo the submission.
9. If your manuscript has been successfully submitted to the Journal you will see a confirmation screen showing your manuscript number, please make a note of your manuscript number and use it in all correspondence. You will also receive an e-mail confirming the submission.
If you do not receive both of these, your manuscript will not have been successfully submitted to the journal and it cannot be progressed through to peer review. If this is the case your manuscript will still be sitting in the Partially Submitted Manuscripts section of your Author centre awaiting your attention.
10. Once the manuscript submission is complete, you can follow its progress through the peer review process in your 'Author Centre' in the submitted manuscript section.
Revising your manuscript
- As with all other decisions, you will be notified of a revision decision by e-mail. Please address the reviewers¡¯ comments in your revised paper, as well as any comments sent to you by the JAC Editorial Office.
- Logon to the Manuscript Central web site as before and, in the 'Author Centre', click on 'Revised Manuscripts'. You will then see the title(s) of any manuscript(s) awaiting revision under 'Manuscript to be revised'.
- If you click on 'View comments/respond' you will see the Editor's comments to you together with the referees' comments. You may cut and paste your response into the text areas at the bottom of the screen. Once you have done this click the 'Save Response' button. Your response will then be sent to the Editor when your revised manuscript is submitted.
- In order to submit your revised manuscript click on the title of your paper. Proceed through the 12 submission screens (altering any necessary information along the way, such as manuscript type). When you reach the File Manager upload the file(s) associated with your revised manuscript, click on 'Save and Continue' and then click on 'Submit your manuscript' if the files have been uploaded to your satisfaction. If your revised manuscript is succesfully submitted you will reveive a confirmatory e-mail.
- It is essential that authors submitting REVISED manuscripts provide high-resolution versions of ALL their figures.
In order for proofs to be produced as quickly and efficiently as possible after acceptance please provide electronic high-resolution images. For further details, please click on the following link:
Alternativley, although less desirable, please send one set of high-resolution, glossy prints to the JAC Editorial Office at the same time that you submit your revised paper.
Support
If you experience any problems during the online submission please contact the JAC Editorial Office.
Peer review
After preliminary examination of the submission by Editorial Office staff to check that all the necessary elements are present, the paper is passed to the Editor-in-Chief. The Editor-in-Chief then assigns the paper to an appropriate Editor. The Editor is responsible for organizing the peer review of the paper. All Reviews, Original articles, Brief reports and Antimicrobial Practice are automatically subject to peer review. The usual number of referees is two, however the Editors reserve the right to make a decision on a paper on the basis of one referee report, or seek the opinion of more than two referees if they judge this to be necessary or desirable. Leading articles and Correspondence are not routinely sent for external refereeing, but the Editor-in-Chief and Editors reserve the right to seek the opinion of one or more external referees if they judge this to be necessary or desirable.
If an Editor decides upon rejection of a paper, it is passed back to the Editor-in-Chief for approval of this decision. All rejection correspondence therefore originates from the Editor-in-Chief. Owing to the increased number of submissions, the Editor-in-Chief and Editors will not enter into correspondence regarding rejection. Authors should regard rejection as final and only resubmit if they can address all the concerns raised and/or have been invited to do so. If the authors seriously suspect misconduct in the handling of their paper they should address their concerns to the Chairman of the Editorial Board for investigation.
Requests that a revised version of a paper be submitted for consideration are sent direct from the Editor responsible to the corresponding author. Any revised version should be submitted within 6 weeks of the revision request or the Journal reserves the right to consider the manuscript as a new submission that may be subject to further refereeing.
The Editor-in-Chief and Editors reserve the right to request more rounds of revision and resubmission, or reject a paper outright, if they judge that any revised version does not adequately address the concerns raised by the referees and the Editor. Once the Editor is satisfied that a revised version has adequately dealt with any points raised they may accept the paper.
After acceptance the paper is sent for copy editing and typesetting prior to production of proofs for author correction.
The Journal maintains the right to edit any paper to the extent necessary to achieve clarity and precision of expression and to conform with English usage and the Journal¡¯s conventions.
Proofs
Proofs are sent to the corresponding author by e-mail as a pdf. These should be read carefully, paying particular attention to any tables, figures and references, corrected and returned to the JAC Editorial Office as soon as possible. Authors should pay particular attention that they check any dosage directions, owing to the seriousness of any error entering the printed record. Extensive changes at the proof stage are not permitted. Authors may be charged for correction of their non-typographical errors. In the event of important developments in a field that affect the paper arising after the final revision, a ¡®Note added in proof¡¯ may be permitted.
JAC Advance Access
JAC Advance Access is the Journal's system for the early online publication of articles ahead of the monthly printed journal issue. Advance Access papers are posted once a fortnight, in exactly the same format as they appear in the issue (i.e. once author and proof-reader corrections have been incorporated). JAC Advance Access significantly reduces time from acceptance to publication for JAC articles (to approximately 8 weeks). If you are a subscriber to the Journal you can view the Advance Access papers by visiting www.jac.oupjournals.org and clicking the Advance Access link.
Offprints
An offprint order form will be sent to the corresponding author with the proofs. Free online access is available for Leading articles, Reviews, Original articles, Brief reports and Antimicrobial practice (the URL provided can be distributed in place of offprints). No free offprints will be provided, but authors wishing to purchase offprints can do so via the order form.
Editorial Board
Editor-in-Chief:
Professor D S Reeves
JAC Editorial Office
11 The Wharf
16 Bridge Street
Birmingham B1 2JS
Email: jac@bsac.org.uk
Editors:
M B Avison
P M Bennett*
T C J Boswell
N M Brown
P L Chiodini
J P Donnelly*
H J Field*
J E Foweraker
A P Fraise
A M Geretti
F K Gould
P A James
A P Johnson
N Kennedy
K G Kerr
S Khoo
R J Koerner
A M Lovering
E M E MacMahon
T D McHugh
I Morrissey
F C Odds
S J Pedler
S Simjee
J M Symonds
E J Threlfall
A P R Wilson*
T G Winstanley
N Woodford
*Also members of the Editorial Board
Editorial Manager:
C W E Drummond
Statistical Adviser:
A J Hedges
Editorial Board:
R Wise (Chairman) UK
J M Andrews, UK
A J Bint, UK
D F J Brown, UK
A F B Cheng, Hong Kong
A Dalhoff, Germany
F Daschner, Germany
D W Denning, UK
J J Eron, USA
I D Farrell**, UK
D Felmingham, UK
L M Fisher, UK
J Garau, Spain
J A Garc¨ªa-Rodr¨ªguez, Spain
H Giamarellou, Greece
S H Gillespie, UK
M R Gismondo, Italy
H Goossens, Belgium
J R Graybill, USA
R N Gruneberg, UK
F G Hayden, USA
K Hiramatsu, Japan
P Huovinen, Finland
G Kahlmeter, Sweden
S B Levy, USA
P T Ljungman, Sweden
S A Locarnini, Australia
H Lode, Germany
A P MacGowan**, UK
J Morschhauser, Germany
L R Peterson, USA
M A Pfaller, USA
M D Richardson, Finland
T V Riley, Australia
M C Roberts, USA
E Rubinstein, Israel
S Rusconi, Italy
S L Sacks, Canada
G C Schito, Italy
P M Shah, Germany
J Shimada, Japan
H Vanden Bossche, Belgium
D W Warnock, USA
B Wiedemann, Germany
S H Zinner, USA
**Present as Officers of the BSAC
Publishers: Sending Books for Review
|
刊名字顺( Alphabetical List of Journals):
返回页首 